Ubiquitin-protein ligase E3 component n-recognin 1 and 2 (UBR1/UBR2)

UBR1 and UBR2 are key E3 ubiquitin ligases that serve as the primary recognition components, or N-recognins, of the Arg/N-degron pathway, a proteolytic system where the N-terminal residue of a protein determines its metabolic stability (UniProt P33209, Q8IWV8). These enzymes utilize a specialized UBR box domain to bind destabilizing N-terminal residues, such as basic or bulky hydrophobic amino acids, subsequently facilitating the transfer of ubiquitin to the substrate for proteasomal degradation (Varshavsky, 2011, PMID: 21888068). UBR1 is critically linked to Johanson-Blizzard syndrome, a rare congenital disorder characterized by exocrine pancreatic insufficiency and physical malformations (Zenker et al., 2005, PMID: 16244673). UBR2 plays a significant role in chromosome pairing during meiosis and has been implicated in the pathogenesis of cancer cachexia by promoting muscle protein breakdown (Kwon et al., 2001, PMID: 11435592). In pharmaceutical research, UBR1 and UBR2 are being explored as alternative E3 ligases for Proteolysis Targeting Chimeras (PROTACs) to enable the degradation of proteins that may not be accessible via traditional ligases like CRBN or VHL (Hwang et al., 2022, PMID: 35115412). Modulating these ligases offers potential therapeutic avenues for treating metabolic disorders, muscle wasting, and certain malignancies.

Other names

Ubiquitin-protein ligase E3 component n-recognin 1Ubiquitin-protein ligase E3 component n-recognin 2E3 alpha-1E3 alpha-2N-recognin-1N-recognin-2UBR1UBR2

UBR1 and UBR2 act as E3 ligases that recognize specific N-terminal amino acids (N-degrons) of substrate proteins through their UBR box domains. Upon binding, they facilitate the E2-dependent polyubiquitination of the substrate, marking it for degradation by the 26S proteasome (Sriram & Kwon, 2010, PMID: 20603580).